Literature DB >> 12964009

Role of antioxidant genes for the activity of artesunate against tumor cells.

Thomas Efferth1, Margaret M Briehl, Margaret E Tome.   

Abstract

The antimalaria drug, artesunate (ART), is very cytotoxic in tumor cell lines. The active moiety of ART is an endoperoxide bridge that generates carbon-centered free radicals and oxidative stress upon cleavage. Oxidative stress appears to be necessary for the antimalarial activity of ART. To test whether antioxidant gene expression affects the ART response in tumor cell lines we compared the baseline antioxidant mRNA gene expression in the 55 human tumor cell line panel from the National Cancer Institute Developmental Therapeutics Program to the ART IC50. Thioredoxin reductase expression showed a significant positive correlation to the ART IC50 and catalase expression was inversely correlated with the ART IC50 (p<0.05). WEHI7.2 mouse thymoma cells selected for resistance to hydrogen peroxide or transfected with thioredoxin, manganese superoxide dismutase, catalase or bcl-2 showed resistance to ART compared to the parental cell line. Taken together these data support a role for oxidative stress in the mechanism of ART action in tumor cells and suggest that antioxidant defenses act in combination to affect the cellular response to ART.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964009

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  26 in total

1.  Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells.

Authors:  Margaret E Tome; Melba C Jaramillo; Margaret M Briehl
Journal:  Free Radic Biol Med       Date:  2011-09-10       Impact factor: 7.376

2.  Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.

Authors:  Ze-Shun Zhang; Jing Wang; You-Bi Shen; Cheng-Cheng Guo; K E Sai; Fu-Rong Chen; Xin Mei; F U Han; Zhong-Ping Chen
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

Review 3.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

4.  Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.

Authors:  Mehmet Berköz; Ferbal Özkan-Yılmaz; Arzu Özlüer-Hunt; Mirosław Krośniak; Ömer Türkmen; Duygu Korkmaz; Sıddık Keskin
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

5.  Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production.

Authors:  Anne Hamacher-Brady; Henning A Stein; Simon Turschner; Ina Toegel; Rodrigo Mora; Nina Jennewein; Thomas Efferth; Roland Eils; Nathan R Brady
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

Review 6.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

7.  Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line.

Authors:  Shokoofe Noori; Zuhair M Hassan; Vida Farsam
Journal:  Chin J Integr Med       Date:  2013-06-15       Impact factor: 1.978

8.  Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells.

Authors:  V Badireenath Konkimalla; Martina Blunder; Bernhard Korn; Shahid A Soomro; Herwig Jansen; Wonsuk Chang; Gary H Posner; Rudolf Bauer; Thomas Efferth
Journal:  Nitric Oxide       Date:  2008-04-22       Impact factor: 4.427

9.  Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo.

Authors:  Ji-Hui Du; Hou-De Zhang; Zhen-Jian Ma; Kun-Mei Ji
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-19       Impact factor: 3.333

Review 10.  Artemisinins: their growing importance in medicine.

Authors:  Sanjeev Krishna; Leyla Bustamante; Richard K Haynes; Henry M Staines
Journal:  Trends Pharmacol Sci       Date:  2008-08-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.